Kristen Lee, MD
About Kristen Lee, MD
Kristen Lee, MD, serves as the Senior Medical Director of Clinical Development at Sana Biotechnology, Inc. and holds an academic position as an Assistant Professor at NYU Langone Health, with extensive experience in rheumatology and clinical research.
Work at Sana Biotechnology
Kristen Lee serves as the Senior Medical Director of Clinical Development at Sana Biotechnology, Inc. since 2024. In this role, she focuses on developing strategies for future clinical trials, particularly those aimed at expanding the use of allogeneic CAR T cells targeting CD19+ in autoimmune diseases. Her position is based in South San Francisco, California, where she contributes to the advancement of innovative therapies.
Current Role at NYU Langone Health
In addition to her role at Sana Biotechnology, Kristen Lee has been an Assistant Professor at NYU Langone Health since 2012. This concurrent academic position allows her to engage in both clinical practice and education, where she imparts her extensive knowledge in rheumatology and clinical development to students and colleagues.
Previous Experience at Pfizer
Kristen Lee previously worked at Pfizer in various capacities within the Inflammation and Immunology division. She served as the Senior Medical Director, Rheumatology Lead in Medical Affairs from 2020 to 2023, and as a Clinician in Research and Development for a brief period in 2023. Her experience at Pfizer contributed to her expertise in rheumatology and clinical development.
Education and Expertise
Kristen Lee holds a Doctor of Medicine (MD) degree from Stony Brook University, achieved in 2007. She completed her Internal Medicine and Rheumatology Fellowship at NYU Grossman School of Medicine from 2007 to 2012. Additionally, she earned a Master of Science in Nursing from Yale School of Nursing, focusing on Adult Primary Care, and a Bachelor of Science in Biochemistry from UCLA. Her educational background supports her deep therapeutic knowledge in rheumatology.